✓ Written by Cognizil Editorial Team📅 Updated: August 2026✓ Sources cited & fact-checked🔒 Official site — cogniszil.com
Supplement Safety

CYP3A4: The Enzyme Behind Most Drug Interactions

Disclosure: cogniszil.com is the Cognizil official website and earns revenue from product orders placed through this site. Content is written by our editorial team and cites public research sources. Statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. See our editorial policy and disclaimer.

One liver enzyme is responsible for a disproportionate share of drug interaction warnings, and understanding it makes those warnings make sense.

What it does

CYP3A4 is a cytochrome P450 enzyme expressed in the liver and small intestine. It metabolises a very large proportion of clinically used drugs, which is why it dominates interaction pharmacology. Its intestinal expression means it contributes to first-pass metabolism, reducing how much of an oral dose reaches circulation at all. It works alongside P-glycoprotein, and many compounds affect both.

Induction versus inhibition

Induction increases enzyme production, so drugs are cleared faster and blood levels fall. This takes days to weeks to develop as new enzyme is synthesised, and takes a similar period to reverse after stopping the inducer - which means the interaction persists after you stop the supplement, and levels shift again when the enzyme returns to baseline. Inhibition is usually faster in onset, blocking existing enzyme, and raises drug levels, potentially into toxic ranges.

Looking at the Cognizil official website? Pricing starts at $49 per bottle on the 6-bottle tier.

See Cognizil Pricing

Why direction matters clinically

Induction is dangerous for drugs with a defined therapeutic requirement - contraceptives that stop preventing pregnancy, immunosuppressants that stop preventing rejection, antiretrovirals that stop suppressing viral load. Inhibition is dangerous for drugs with a narrow therapeutic index, where a modest rise in level produces toxicity. Neither is a theoretical concern: both have documented clinical consequences in the published literature.

Key takeaways

  • CYP3A4 metabolises a very large share of clinically used drugs
  • Induction takes days to weeks to develop and a similar period to reverse
  • Induction lowers drug levels; inhibition raises them
  • Both directions have documented clinical consequences

A note on Cognizil

We publish this blog on the Cognizil official website, so treat anything we say about our own product as coming from an interested party. What we can do is be specific: Cognizil is a liquid dropper supplement taken once daily, and it makes no claim to treat, cure or prevent any disease. It also contains St. John’s Wort, so if you take any prescription medicine, read our interaction guide before the sales page. If you want the drawbacks first, start with Cognizil reviews and complaints.

Cognizil™ — Official Site Pricing

Liquid advanced memory support with Ginkgo Biloba, Bacopa Monnieri, St. John’s Wort, N-Acetyl L-Carnitine, Huperzine-A and Phosphatidylserine. Stimulant-free, taken once daily by dropper.

Check Cognizil AvailabilityFrom $49 per bottle on the 6-bottle tier · free US shipping on 6 bottles · 60-day money-back guaranteeInteraction notice: contains St. John’s Wort. If you take any prescription medicine, including hormonal contraception, check the interaction list and speak to a pharmacist first.
← PreviousHerb-Drug Interactions: How They Actually HappenNext →Why Supplements Must Stop Before Surgery
CZ
About the author

Cognizil Editorial Team

We research, write and maintain every page on the Cognizil official website. Our team reads the product label and supplier documentation directly, cross-checks each ingredient against public research databases such as PubMed, the NIH Office of Dietary Supplements and NCCIH, and updates pages whenever the formula, price or refund terms change. Read our editorial policy to see how we source and correct information.

↑